Procaps Group S.A. (NasdaqGM:PROC) (?Procaps? or the ?Company?) announced that it is conducting a process to explore strategic alternatives to maximize shareholder value. As part of this process, the company plans to consider a wide range of options, all to accelerate growth and optimize shareholder value.

As previously communicated, Jose Vieira, Procaps newly appointed Chief Executive Officer, will continue to develop a detailed strategic plan, working closely with Ruben Minski, Executive Chairman, and the Company?s Board of Directors. Ruben Minski noted: ?We are thrilled with Jose Vieira?s progress in developing strategies to set Procaps up for a prosperous future, and we look forward to sharing with you our organic strategic plans. Simultaneously, as part of our commitment to our shareholders, we wanted to ensure that all available options for accelerating Procaps?

growth are thoroughly explored, maximizing value for our shareholders. The Company has retained BTG Pactual, a leading Latin American Investment Bank, to explore these alternatives over the next few quarters and it has also formed a 2-person Strategic Committee, led by Jose Minski and Alejandro Weinstein, both meaningful shareholders of Procaps, with a long track record of creating value together across multiple platforms via M&A. This committee was formed in order to create total alignment and common objectives between majority and minority shareholders and will have full authority to make recommendations to the Board of Directors for their approval. Jose Minski stated: ?We fully support Jose Vieira as he transitions into the leadership role from Ruben, and aim to help him succeed.

Alejandro and I will work closely together with Mr. Vieira and the Company?s Board of Directors to help determine the best strategy that optimizes the outcome for our fellow shareholders. We remain excited about the Company?s future growth prospects and the value proposition that Procaps can deliver to its customers.? Mr. Weinstein commented: ?Procaps is a unique organization that provides innovative and differentiated products and solutions for the healthcare and pharmaceutical community.

I am now fully aligned with Procaps? Board that the best way to maximize value for shareholders is to comprehensively review the Company?s strategic alternatives, including avenues to accelerate growth through opportunistic M&A activities. We will pursue the pathway that maximizes value for all of our shareholders and also ensures successful outcomes for Procaps customers and employees.?

There can be no assurance regarding the results or outcome of this strategic review. Procaps does not intend to comment further on this strategic review process, and it will make further announcements in accordance with its ongoing disclosure obligations and pursuant to applicable laws and regulations.